Market Consultation regarding the Purchase of the Medication Polatuzumab vedotin AI
Expired
Market Consultation
33652000 - Antineoplastic and immunomodulating agents
TEDAS your procurement assistant
Ask a question about this procurement
t
Object of Purchase
What is being purchased: The medication Polatuzumab vedotin (Products).
Main technical requirements, specifics:
Specific preparation being purchased: Polatuzumab vedotin 140mg inf. (ATC code: 33652000-5).
Estimated quantity: 7 vials (flac).
Priority is given to registered medicinal products.
The supplier must indicate “Named” if the medicine is supplied in accordance with the Order of the Minister of the Republic of Lithuania on the Rules for the Procurement…
👋 Hello! I am TEDAS – your procurement assistant 💼✨
What would you like to know about this procurement?
Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...
Kvietimas dalyvauti rinkos konsultacijoje.pdf
Rinkos konsultacijos klausimynas_2 priedas.docx
Techninė specifikacija (projektas)_1 priedas_.pdf
Buyer contracts
Main information
Procurement number
6444869
Procurement type
Market Consultation
Deadline
Published date
Value
N/A
Procurement object type
Prekės
Buyer
Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos (PV)
Description
Rinkos konsultacijos tikslas, tinkamai pasirengti Pirkimui ir iki Pirkimo pradžios informuoti rinkos dalyvius bei kitus suinteresuotus asmenis apie ketinimą vykdyti Pirkimą bei reikalavimus ir gauti rinkos dalyvių ir kitų suinteresuotų asmenų pasiūlymus, pastabas, rekomendacijas techninei specifikacijai.
Procurement categories
33652000 - Antineoplastic and immunomodulating agents